Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Home
/
Trials
/
NCT00457171
NCT00457171
View on ClinicalTrials.gov
GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis
PHASE1
Terminated
INTERVENTIONAL
Enrollment
16
Participants
Timeline
Start Date
December 31, 2004
Conditions
Ulcerative Colitis
Interventions
DRUG
GI-270384
Sponsors
Lead Sponsor
GlaxoSmithKline
All Listed Sponsors
lead
GlaxoSmithKline
INDUSTRY
NCT00457171 - GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis | Biotech Hunter | Biotech Hunter